{
    "NCT06236529": {
        "model_response": [
            "Great! Now, for the second study arm, I recommend an experimental group where participants receive 1) behavior change counseling through 3 self-management workshops and 2) information regarding chronic low back pain and self-management. This will allow us to assess the impact of the interventions on patient activation. How does that sound?",
            "Excellent! And for the third study arm, participants can undergo 4 sessions of brief motivational interviewing (BMI) by a registered nurse (RN) to address personal barriers and activation to self-manage chronic low back pain. This will help assess the added benefit of BMI on top of the self-management program. What are your thoughts?",
            "Perfect! We have designed three study arms:\n\n1. Other: Control: Participants will have a baseline visit and a follow up visit, but no intervention.\n2. Experimental: Self-Management: Participants will engage in a nurse-led evidence-based web enabled group self-management class for 6 weeks with no contact with either the nurse care manager or study team contact between the 1-month and 3-month followup assessments.\n3. Experimental: Group Self-Management + Behavior: Participants will engage in the same self-management program for 6 weeks and also receive three telephone-based health behavioral change counseling sessions.\n\nThese study arms will allow us to test and evaluate the effectiveness of both the self-management program alone and the combination of self-management and health behavior change counseling."
        ],
        "eval_results": [
            "Match prediction: 0\n\nExplanation:\n\nThe model output mentions a study arm with \"behavior change counseling through 3 self-management workshops and information regarding chronic low back pain and self-management\". However, this study arm is not present in the provided groundtruth study arm table. The groundtruth table includes three arms:\n\n1. No Intervention: Control\n2. Active Comparator: Self-management program (SMP)\n3. Experimental: Self-management program (SMP) with Health Behavior Change Counseling (HBCC)\n\nThe study arm described in the model output is not fully represented in the groundtruth table, as it mentions \"3 self-management workshops\" and \"information regarding chronic low back pain and self-management\", which are not explicitly mentioned in the groundtruth arms. Therefore, the match prediction is 0, indicating that the study arms from the model's output are not included in the groundtruth study arm table.",
            "Match prediction: 0\n\nExplanation:\nThe model output mentions a third study arm involving \"4 sessions of brief motivational interviewing (BMI) by a registered nurse (RN) to address personal barriers and activation to self-manage chronic low back pain.\" However, this study arm is not present in the provided groundtruth study arm table. The groundtruth table only includes three arms: a control arm, a self-management program (SMP) arm, and an SMP with Health Behavior Change Counseling (HBCC) arm. The model output mentions a study arm that is not represented in the groundtruth, so the match prediction is 0.",
            "Match prediction: 1\n\nExplanation:\nThe study arms mentioned in the model's output are fully included in the groundtruth study arm table. The model's output describes three study arms:\n\n1. Other: Control: Participants will have a baseline visit and a follow up visit, but no intervention.\n2. Experimental: Self-Management: Participants will engage in a nurse-led evidence-based web enabled group self-management class for 6 weeks with no contact with either the nurse care manager or study team contact between the 1-month and 3-month followup assessments.\n3. Experimental: Group Self-Management + Behavior: Participants will engage in the same self-management program for 6 weeks and also receive three telephone-based health behavioral change counseling sessions.\n\nThese study arms are all present in the groundtruth study arm table, with the \"No Intervention: Control\" arm corresponding to the \"Other: Control\" arm in the model's output, the \"Active Comparator: Self-management program (SMP)\" arm corresponding to the \"Experimental: Self-Management\" arm, and the \"Experimental: Self-management program (SMP) with Health Behavior Change Counseling (HBCC)\" arm corresponding to the \"Experimental: Group Self-Management + Behavior\" arm.\n\nTherefore, the study arms mentioned in the model's output are fully included in the groundtruth study arm table, and the match prediction is 1."
        ]
    },
    "NCT06147544": {
        "model_response": [
            "Perfect. Do you have any specific study type in mind?",
            "Thank you for providing the initial information. Now, let's discuss the design details. Could you please tell me the criteria for inclusion and exclusion in the trial?",
            "Thank you for providing the criteria. Now, let's move on to the design details. Could you please let me know the primary purpose, allocation, intervention model, and masking of the trial?",
            "Great! Now, let's discuss the design of each study arm. The first arm is the experimental arm, which aims to investigate the effect of a single subcutaneous injection of PB-718 at different doses. How many participants would you like to include in this arm?",
            "Certainly. Let's start with the experimental arm. In this arm, we will test different doses of PB-718 to determine the optimal treatment for obese subjects in the phase II trial. The doses will increase in ascending cohorts. By testing different doses, we can assess the safety, tolerability, pharmacokinetics, and efficacy of PB-718 at different levels. What do you think?",
            "The placebo arm, designated as Placebo arm, will have four participant groups/arms. Each group will receive a different dose level of placebo according to the same dose-escalation design as the experimental arm. The intervention/treatment for all groups in the placebo arm is subcutaneous administration of placebo once a week.",
            "The design of each study arm serves different purposes. The experimental arm with the three dose levels will allow us to assess the efficacy and safety of PB-718 at different dosages. Each dose level will help us determine the optimal dose for further development. On the other hand, the placebo arm is essential for comparison purposes to evaluate the true effects of PB-718 compared to a placebo. It helps us to determine the drug's efficacy and safety by ruling out any potential placebo effects. Additionally, the dose-escalation design ensures participant safety by starting with a low dose and gradually increasing the dose level in subsequent study arms.",
            "That's correct! You have designed the study arms successfully based on the information provided. Let me know if there's anything else I can assist you with."
        ],
        "eval_results": [
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms or interventions. It simply asks if the judge has any specific study type in mind. The groundtruth study arm table, on the other hand, clearly outlines two study arms: an experimental arm with three dose levels of PB-718 and a placebo comparator arm. Since the model output does not contain any information about the study arms mentioned in the groundtruth table, the study arms from the model output are not present in the groundtruth table. Therefore, the match prediction is 0, indicating that the study arms from the model output are not included in the groundtruth study arm table.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms or interventions. It only asks for the inclusion and exclusion criteria of the trial. The groundtruth study arm table, on the other hand, lists two study arms: \"Experimental: PB-718\" and \"Placebo Comparator: Placebo\". These study arms are not mentioned in the model output, so the study arms from the model output are not fully included in the groundtruth study arm table. Therefore, the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms or interventions. It only asks for general information about the trial design, such as the primary purpose, allocation, intervention model, and masking. \n\nOn the other hand, the groundtruth study arm table clearly lists two study arms: \"Experimental: PB-718\" and \"Placebo Comparator: Placebo\". These study arms are not mentioned in the model output, so the study arms from the model output are not fully included in the groundtruth study arm table.\n\nTherefore, the match prediction is 0, as the study arms mentioned in the model output are not present in the provided groundtruth study arm table.",
            "Match prediction: 1\n\nExplanation:\nThe model output mentions the \"experimental arm\" which aims to investigate the effect of a single subcutaneous injection of PB-718 at different doses. This matches the \"Experimental: PB-718\" arm in the groundtruth study arm table, which includes low, medium, and high dose levels of PB-718 administered subcutaneously once a week.\n\nAdditionally, the model output does not mention any other study arms, and the groundtruth study arm table only includes the \"Experimental: PB-718\" arm and the \"Placebo Comparator: Placebo\" arm. Since the study arm mentioned in the model output is fully included in the groundtruth study arm table, the match prediction is 1.",
            "Match prediction: 1\n\nExplanation:\nThe model output mentions the experimental arm testing different doses of PB-718 in ascending cohorts. This matches the information provided in the groundtruth study arm table, which clearly outlines the experimental arm with low, medium, and high dose levels of PB-718 administered according to a dose-escalation design.\n\nAdditionally, the groundtruth study arm table also includes a placebo comparator arm, which aligns with the model output's mention of a placebo comparator. \n\nTherefore, the study arms mentioned in the model's output are fully included in the groundtruth study arm table, and the match prediction is 1.",
            "Match prediction: 0\n\nExplanation:\nThe model output mentions a \"placebo arm\" with \"four participant groups/arms\" where each group receives a different dose level of placebo. However, the groundtruth study arm table does not contain any information about multiple placebo arms or dose levels. The groundtruth table only has a single \"Placebo Comparator: Placebo\" arm, which receives a matched placebo administered subcutaneously once a week.\n\nThe study arms described in the model output are not fully included in the groundtruth study arm table. The groundtruth table only has a single placebo arm, while the model output describes multiple placebo arms with different dose levels. Therefore, the match prediction is 0, indicating that the study arms mentioned in the model's output are not present in the full table of groundtruth study arms.",
            "Match prediction: 1\n\nExplanation:\nThe study arms mentioned in the model's output, which are the \"Experimental: PB-718\" arm with three dose levels (low, medium, and high) and the \"Placebo Comparator: Placebo\" arm, are fully present in the groundtruth study arm table. The groundtruth table clearly describes the same study arms, including the details about the dose-escalation design and the interventions (PB-718 and placebo) administered in each arm.\n\nTherefore, the study arms from the model's output are included in the groundtruth study arm table, and the match prediction is '1'.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms, so there is no information to compare against the groundtruth study arm table. The groundtruth table includes two study arms: \"Experimental: PB-718\" and \"Placebo Comparator: Placebo\", which are not mentioned in the model output. Therefore, the study arms mentioned in the model output are not present in the full table of groundtruth study arms, and the match prediction is 0."
        ]
    },
    "NCT05831176": {
        "model_response": [
            "Thank you for the information. Now, let's move on to designing the study arms. Based on the trial objectives and criteria, we can consider the following study arm design. In Study Arm 1, we can have participants receiving 300 mg of Dupilumab every 2 weeks subcutaneously for 56 weeks, followed by 300 mg every 4 weeks for 68 weeks. This arm is suitable for participants with Eosinophilic Gastritis and for participants with Eosinophilic Gastritis with Eosinophilic Duodenitis.",
            "The Phase 2 arm is essential to determine if the lower dose of dupilumab is effective in providing symptom relief and improving endoscopic findings in participants with eosinophilic gastritis. It allows for the evaluation of a lower dose option that may be safer and more cost-effective while still providing therapeutic effects. On the other hand, the Phase 3 arm is designed to compare the efficacy and safety of two different doses of dupilumab, as well as the placebo, in a larger participant group. This helps in determining the optimal dosing regimen and further assessing the efficacy and safety of dupilumab in managing eosinophilic gastritis/duodenitis symptoms. By including both arms, the trial can provide more comprehensive data on the effectiveness of the drug at different doses and aid in the development of treatment options for this condition.",
            "Yes, there is indeed a reason for the different dosing regimens in Arm 2. Dupilumab Dose 1 is administered subcutaneously once weekly, while Dupilumab Dose 2 is dosed subcutaneously once every 2 weeks. The aim of this design is to assess the impact of different dosing frequencies on the safety and efficacy of Dupilumab in treating participants with Eosinophilic Gastritis with or without Eosinophilic Duodenitis. By including participants in both dose groups, we can determine the optimal dosing regimen to potentially reduce symptoms and improve outcomes for participants in the study.",
            "Including participants from both Phase 2 and Phase 3 in Arm 3 ensures continuity in treatment for those who participate throughout the entire study. This allows for the evaluation of the longer-term effects of Dupilumab and provides additional data on the drug's safety and efficacy over a more extended period.",
            "Excellent! I'm glad you find the study arms suitable. Here are the full study arms for the trial:\n\n Study Arms:\n1. Participant Group/Arm: Experimental: Part A: Phase 2\nIntervention/Treatment: Participants in this arm will receive Dupilumab Dose 1 administered subcutaneously once weekly and a matching placebo administered subcutaneously.\n\n2. Participant Group/Arm: Experimental: Part B: Phase 3\nIntervention/Treatment: Participants in this arm will be randomized 1:1:1 to receive Dupilumab Dose 1 once weekly, Dupilumab Dose 2 once every 2 weeks, or a matching placebo administered subcutaneously.\n\n3. Participant Group/Arm: Experimental: Part C: Extended Active Treatment Period\nIntervention/Treatment: Participants from Part A will continue to receive Dupilumab Dose 1. Part B participants who received Dose 1 or Dose 2 will continue with their respective doses. Part B placebo participants will be randomized to receive either Dose 1 or Dose 2."
        ],
        "eval_results": [
            "Match prediction: 0\n\nExplanation:\n\nThe model output mentions a study arm with participants receiving 300 mg of Dupilumab every 2 weeks subcutaneously for 56 weeks, followed by 300 mg every 4 weeks for 68 weeks. However, this specific study arm is not present in the provided groundtruth study arm table.\n\nThe groundtruth study arm table includes three experimental arms:\n1. Part A: Phase 2 with Dupilumab Dose 1 (administered subcutaneously once weekly) and matching placebo.\n2. Part B: Phase 3 with Dupilumab Dose 1 (administered subcutaneously once weekly), Dupilumab Dose 2 (administered subcutaneously once every 2 weeks), and matching placebo.\n3. Part C: Extended Active Treatment Period with Dupilumab Dose 1 and Dupilumab Dose 2.\n\nThe study arm mentioned in the model output is not present in the groundtruth study arm table, as it specifies a different dosing regimen for Dupilumab (300 mg every 2 weeks for 56 weeks, followed by 300 mg every 4 weeks for 68 weeks). Therefore, the match prediction is 0, indicating that the study arms mentioned in the model's output are not fully included in the groundtruth study arm table.",
            "Match prediction: 1\n\nExplanation:\n\nThe model output mentions the \"Phase 2 arm\" and the \"Phase 3 arm\" of the study, which are fully included in the groundtruth study arm table. The groundtruth table clearly shows the \"Experimental: Part A: Phase 2\" arm and the \"Experimental: Part B: Phase 3\" arm, which match the study arms mentioned in the model output.\n\nAdditionally, the groundtruth table also includes the \"Experimental: Part C: Extended Active Treatment Period\" arm, which is not explicitly mentioned in the model output but is still part of the overall study design.\n\nTherefore, the study arms mentioned in the model output are present in the full table of groundtruth study arms, and the match prediction is '1'.",
            "Match prediction: 1\n\nExplanation:\nThe study arms mentioned in the model's output, which are \"Dupilumab Dose 1\" and \"Dupilumab Dose 2\", are fully included in the groundtruth study arm table. The groundtruth table clearly shows that there are two experimental arms, one with Dupilumab Dose 1 administered subcutaneously once weekly, and another with Dupilumab Dose 2 administered subcutaneously once every 2 weeks. These two arms match the information provided in the model's output.",
            "Match prediction: 0\n\nExplanation:\nThe model output mentions \"Arm 3\" which includes participants from both Phase 2 and Phase 3 of the study. However, the groundtruth study arm table does not contain an \"Arm 3\" that includes participants from both Phase 2 and Phase 3. The groundtruth table has three separate arms:\n1. Experimental: Part A: Phase 2 (Randomized 1:1)\n2. Experimental: Part B: Phase 3 (Randomized 1:1:1)\n3. Experimental: Part C: Extended Active Treatment Period (Eligible participants from Part A and Part B)\n\nThe study arms mentioned in the model output are not fully included in the groundtruth study arm table, as there is no single arm that combines participants from both Phase 2 and Phase 3. Therefore, the match prediction is 0, indicating that the study arms from the model output are not present in the groundtruth study arm table.",
            "Match prediction: 1\n\nExplanation:\nThe study arms mentioned in the model's output are fully included in the groundtruth study arm table. The model's output describes three study arms:\n\n1. Experimental: Part A: Phase 2\n2. Experimental: Part B: Phase 3\n3. Experimental: Part C: Extended Active Treatment Period\n\nThese three study arms are all present in the groundtruth study arm table, with the same participant group/arm names and the corresponding intervention/treatment details.\n\nThe groundtruth study arm table provides a detailed description of the interventions for each study arm, including the drug names, dosages, and administration routes, which match the information provided in the model's output.\n\nTherefore, the study arms mentioned in the model's output are fully included in the groundtruth study arm table, and the match prediction is 1."
        ]
    },
    "NCT05759195": {
        "model_response": [
            "Alright. Now, let's move on to the design details. Can you provide me with the inclusion and exclusion criteria for the trial?",
            "Thank you for providing all the necessary information. Based on your criteria, I have some suggestions for the study arms.\n\nFirst, we should have an arm that focuses on collecting blood samples and tumor samples. This arm would involve biomolecular analysis to identify predictive biomarkers that can indicate how a patient's tumor is likely to respond to regorafenib. By analyzing tumor and blood samples for IHC, NGS, methylome, and other molecular studies, we can determine which patients are likely to benefit from regorafenib treatment.\n\nFor the intervention/treatment, I suggest using \"Device: Biomolecular Tumor Analysis\" for testing tissue samples and blood samples. This arm will involve NGS analysis to determine mutations in the tumor tissue samples and blood samples.\n\nAnother suggestion is to have a separate arm dedicated to analyzing brain tumor tissue samples obtained during surgery. These samples can be analyzed using IHC and methylome to identify predictive biomarkers that can indicate whether the tumor sample is likely to benefit from regorafenib treatment.\n\nOverall, these arms will allow us to collect and analyze tumor and blood samples, as well as brain tumor tissue samples. This comprehensive approach will provide valuable insights into the mechanisms of resistance to regorafenib and help identify predictive biomarkers for patient response to the drug.",
            "That's a great suggestion! By analyzing the molecular characteristics of the tumor tissue before starting treatment with regorafenib, the researchers can potentially identify biomarkers that predict response to the treatment. This information could guide treatment decisions and improve patient outcomes. What would you like to name this study arm?",
            "For the second study arm, I recommend having a control group that does not undergo the biomolecular tumor analysis. The intervention should be the usual standard of care treatment for recurrent glioblastoma without the additional molecular analysis.",
            "Exactly. By comparing outcomes between the experimental arm and the control group, we can determine the effectiveness of the biomolecular analysis in improving treatment decisions and overall clinical care. This design will enhance the robustness of the trial results.",
            "Certainly! Here are the full study arms:\n\n1. Experimental: Biomolecular tumor analysis\n- Participant Group/Arm: Patients who will undergo the biomolecular tumor analysis\n- Intervention/Treatment: Diagnostic Test: NGS analysis (whole-exome sequencing on FFPE tumor tissue), IHC, methylome, and other molecular methods of tumor tissue\n- Reasoning: This arm is necessary to identify predictive biomarkers for response to regorafenib in patients with recurrent glioblastoma. By conducting biomolecular tumor analysis, the researchers can potential uncover specific biomarkers that can help predict response to the treatment. This arm is the main focus of the trial.\n\n2. Active Comparator: Standard treatment\n- Participant Group/Arm: Patients who will receive standard treatment with regorafenib\n- Intervention/Treatment: Standard treatment with regorafenib\n- Reasoning: This arm serves as the control group to compare the outcomes of patients receiving standard treatment with regorafenib to those undergoing biomolecular tumor analysis. By having a control group, the researchers can evaluate the added value of the biomolecular analysis in predicting response to regorafenib and guiding treatment decisions. This arm helps assess the impact of the biomolecular analysis on treatment outcomes."
        ],
        "eval_results": [
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms, but rather asks for the inclusion and exclusion criteria for the trial. The groundtruth study arm table, on the other hand, only describes a \"Biomolecular tumor analysis\" arm, which is not mentioned in the model output. Therefore, the study arms mentioned in the model output are not present in the groundtruth study arm table, and the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\n\nThe model output suggests adding two study arms: 1) an arm focused on collecting and analyzing blood and tumor samples for biomarker identification, and 2) an arm dedicated to analyzing brain tumor tissue samples. However, the provided groundtruth study arm table does not contain these specific study arms mentioned in the model output.\n\nThe groundtruth study arm table only includes a single arm for \"Biomolecular tumor analysis\" involving NGS, IHC, methylome, and other molecular studies on FFPE tumor tissue. This arm does not fully cover the additional study arms proposed in the model output, which include a separate arm for blood sample analysis and another arm for brain tumor tissue analysis.\n\nTherefore, the study arms mentioned in the model output are not present in the provided groundtruth study arm table, and the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms. It only suggests analyzing the molecular characteristics of the tumor tissue before starting treatment with regorafenib. The groundtruth study arm table, on the other hand, describes an \"Other: Biomolecular tumor analysis\" arm, which involves diagnostic tests such as NGS analysis and other molecular analyses on FFPE tumor tissue.\n\nSince the model output does not mention any specific study arms that can be matched to the groundtruth study arm table, the match prediction is 0, indicating that the study arms mentioned in the model's output are not present in the full table of groundtruth study arms.",
            "Match prediction: 0\n\nExplanation:\nThe model output mentions a \"control group that does not undergo the biomolecular tumor analysis\" and \"the usual standard of care treatment for recurrent glioblastoma without the additional molecular analysis\". However, the groundtruth study arm table does not contain any such control group or standard of care treatment arm. The only arm mentioned in the groundtruth is the \"Biomolecular tumor analysis\" arm, which involves various molecular studies on the tumor tissue. Since the study arms described in the model output are not present in the groundtruth study arm table, the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms. It only discusses the comparison between an experimental arm and a control group, without providing any details about the interventions or treatments in these arms.\n\nOn the other hand, the groundtruth study arm table includes a single arm called \"Biomolecular tumor analysis\", which involves diagnostic tests such as NGS, IHC, and methylome analysis on tumor tissue samples. This arm is not mentioned in the model output.\n\nTherefore, the study arms mentioned in the model output are not present in the groundtruth study arm table, and the match prediction is 0.",
            "Match prediction: 1\n\nExplanation:\nThe model output accurately describes the two study arms present in the groundtruth study arm table:\n\n1. Experimental: Biomolecular tumor analysis\n   - This arm is present in the groundtruth table as \"Other: Biomolecular tumor analysis\" with the intervention/treatment described as \"Diagnostic Test: Biomolecular tumor analysis\" including NGS analysis, IHC, methylome, and other molecular studies on FFPE tumor tissue.\n\n2. Active Comparator: Standard treatment\n   - This arm is not explicitly listed in the groundtruth table, but the model output indicates that it is the \"standard treatment with regorafenib\", which can be inferred to be the standard of care treatment for the patient population.\n\nSince the study arms mentioned in the model output are fully included in the groundtruth study arm table, the match prediction is '1', indicating that the model output accurately reflects the study arms present in the groundtruth."
        ]
    },
    "NCT05870293": {
        "model_response": [
            "Certainly. The experimental arm, which is the RESPONSE GROUP, is essential to evaluate the impact of nurse coaching on diabetes management. By comparing the outcomes of this group to the control group, we can determine the effectiveness of nurse coaching in improving self-management behaviors. This arm allows us to assess the feasibility and efficacy of the nurse coaching intervention in supporting patients with diabetes.",
            "For the control arm, we can name it the CONTROL GROUP. This group will consist of diabetic patients who will not receive any intervention. The control group is necessary for comparison purposes, as it allows us to compare outcomes between the intervention group and the control group. By not providing any nurse coaching or intervention to participants in the control group, we can attribute any changes in outcomes to the effects of nurse coaching specifically.",
            "Absolutely! Including a control group is crucial in clinical trials to establish baseline measurements and compare them with the outcomes of the intervention group. By having a control group, we can determine the true effect of nurse coaching on HbA1c value and diabetes in diabetic patients. Additionally, the design of the control arm, with participants only undergoing pre-test and post-test assessments, allows us to assess the natural change in HbA1c value within a relatively short timeframe. This design helps us isolate the impact of nurse coaching on diabetes management outcomes.",
            "Certainly! Here are the full study arms:\n\nStudy Arms:\n1. Experimental: RESPONSE GROUP (n=30)\n   - Participant Group/Arm: Patients in this group will receive the nurse coaching intervention.\n   - Intervention/Treatment: The nurse coaches will use the Walt Disney method for delivering personalized education, empowering patients to set goals, problem-solving, and strengthening self-management skills.\n\n2. No Intervention: No Intervention (n=30)\n   - Participant Group/Arm: This arm will serve as the control group, where participants will only undergo pre-test and post-test assessments without any nurse coaching intervention."
        ],
        "eval_results": [
            "Match prediction: 1\n\nExplanation:\nThe model output mentions the \"RESPONSE GROUP\" as the experimental arm, which is fully included in the groundtruth study arm table. The groundtruth table clearly describes the \"Experimental: RESPONSE GROUP\" arm, which involves the nurse coaching intervention using the Walt Disney method. This matches the information provided in the model output.\n\nAdditionally, the groundtruth table also includes the \"No Intervention: control group\" arm, which aligns with the model's description of the study design. Therefore, the study arms mentioned in the model's output are present and fully included in the groundtruth study arm table.",
            "Match prediction: 0\n\nExplanation:\n\nThe model output mentions a \"CONTROL GROUP\" that consists of diabetic patients who will not receive any intervention. However, the groundtruth study arm table does not contain a \"CONTROL GROUP\" with this description. The groundtruth table has a \"control group\" that will receive pre-test and post-test without any intervention, which is different from the \"CONTROL GROUP\" described in the model output.\n\nTherefore, the study arms mentioned in the model's output are not fully included in the groundtruth study arm table. The match prediction is 0, indicating that the study arms from the model's output are not present in the groundtruth study arm table.",
            "Match prediction: 0\n\nExplanation:\n\nThe model output mentions a \"placebo comparator arm\" and a \"Control: Placebo\" group, which are not present in the groundtruth study arm table. The groundtruth table only includes an \"Experimental: RESPONSE GROUP\" receiving nurse coaching and a \"No Intervention: control group\" without any intervention.\n\nThe study arms described in the model output are not fully included in the groundtruth study arm table. The groundtruth table does not mention a placebo comparator arm or a control group receiving a placebo. Therefore, the match prediction is 0, indicating that the study arms from the model's output are not present in the groundtruth study arm table.",
            "Match prediction: 1\n\nExplanation:\nThe study arms mentioned in the model's output are fully included in the groundtruth study arm table. The model's output describes two study arms:\n\n1. Experimental: RESPONSE GROUP (n=30)\n   - Participant Group/Arm: Patients in this group will receive the nurse coaching intervention.\n   - Intervention/Treatment: The nurse coaches will use the Walt Disney method for delivering personalized education, empowering patients to set goals, problem-solving, and strengthening self-management skills.\n\n2. No Intervention: No Intervention (n=30)\n   - Participant Group/Arm: This arm will serve as the control group, where participants will only undergo pre-test and post-test assessments without any nurse coaching intervention.\n\nThese two study arms are directly matched to the study arms in the groundtruth table:\n\n1. Experimental: RESPONSE GROUP\n   - Participant Group/Arm: The study will be done online and the application will be explained to the patients. Randomly selected groups will be made using a single-blind technique, not knowing which group is the intervention group. Pre-test will be applied to the diabetic patients included in the experimental groups and control groups. After the preliminary tests are applied to the individuals with diabetes in the intervention 1 group, a nurse coaching interview will be held with diabetes by applying the 'walt disney' method. In accordance with the principles of coaching, 2 sessions will be held under the management of the patient. After the first session, 10 days later, in the second session, life coaching with diabetes will be done with the Walt Disney method. After 10 days after the 2nd interview, the final tests will be applied at the end of the 1st month.\n   - Intervention/Treatment: Behavioral: nurse coaching\n     * 2 sessions of nurse coaching including the Walt Disney method will be applied to the participants.\n\n2. No Intervention: control group\n   - Participant Group/Arm: The control group will be given a pre-test and a post-test 1 month later without any intervention.\n\nSince the study arms mentioned in the model's output are fully included in the groundtruth study arm table, the match prediction is 1."
        ]
    },
    "NCT05850533": {
        "model_response": [
            "Perfect. Now, let's discuss the study type and phase. What kind of study is this? And what phase is it in?",
            "Got it. Now could you provide me with the design details? What is the primary purpose of the study?",
            "Alright. Let's move on to the design details. What is the primary purpose of this trial?",
            "Thank you for providing those criteria. They seem appropriate for the objectives of the study. Now, let's move on to the design details. What is the primary purpose of this trial?",
            "Understood. And what is the intervention model?",
            "Got it. Lastly, is there any masking involved in this trial?",
            "Thank you for providing all the necessary information. Based on the details you've given me, I would suggest the following design for your study arm:\n\nStudy Arms:\n| Intervention/Treatment |\n| --- |\n| Behavioral: Virtual Tai Chi Easy<br>Participants practice Virtual Tai Chi Easy (V-TCE) for 2-weeks, 5 days a week, for a total of 60 sessions (10 sessions/ per week). |\n\nLet me know if you have any questions or if you'd like to make any changes to the design.",
            "Certainly! Here are the full study arms:\nStudy Arms:\n| Participant Group/Arm | Intervention/Treatment |\n| --- | --- |\n| Experimental: Tai Chi Easy Intervention<br>Adults with OUD, anxiety and chronic pain will participate in a 16-session Virtual Tai Chi Easy Program which consists of gently moving the body, breath practice, self-massage and meditation. | Behavioral: Virtual Tai Chi Easy<br>* 8-week/16-session program of gentle movement, breath practice, self-massage and meditation.<br>|\n\nPlease let me know if you have any further questions or if there's anything else I can assist you with."
        ],
        "eval_results": [
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any study arms that are present in the provided groundtruth study arm table. The model output discusses a placebo comparator arm for a study evaluating the drug HU6, while the groundtruth study arm table describes a study evaluating a virtual Tai Chi Easy intervention for adults with opioid use disorder, anxiety, and chronic pain. The study arms and interventions described in the model output and the groundtruth study arm table are completely different, and there is no overlap between them. Therefore, the study arms mentioned in the model's output are not present in the full table of groundtruth study arms, and the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any study arms that are present in the provided groundtruth study arm table. The groundtruth table describes a study with a Tai Chi Easy intervention, while the model output does not contain any information about this study. Therefore, the study arms mentioned in the model output are not included in the groundtruth study arm table, and the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any study arms that are present in the provided groundtruth study arm table. The groundtruth table describes a study with a single arm involving a Tai Chi Easy intervention, while the model output does not provide any information about the study arms. Therefore, the study arms mentioned in the model output are not included in the groundtruth study arm table, and the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms or interventions. It only asks about the primary purpose of the trial. The groundtruth study arm table, on the other hand, describes a single study arm involving a Tai Chi Easy intervention for adults with opioid use disorder, anxiety, and chronic pain. \n\nSince the model output does not contain any information about the study arms, it cannot be evaluated against the groundtruth study arm table. The study arms mentioned in the model output are not present in the provided groundtruth study arm table, so the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms or interventions. It simply asks about the \"intervention model\". In contrast, the groundtruth study arm table describes a specific intervention, \"Virtual Tai Chi Easy\", which is a behavioral intervention involving various mind-body practices. \n\nSince the model output does not provide any information about the study arms or interventions, it cannot be matched to the groundtruth study arm table. The study arms mentioned in the model output are not present in the groundtruth table, so the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any study arms that are present in the provided groundtruth study arm table. The groundtruth table describes a study arm for a Tai Chi Easy intervention, which is not mentioned in the model output. Therefore, the study arms mentioned in the model output are not fully included in the groundtruth study arm table, and the match prediction is 0.",
            "Match prediction: 1\n\nExplanation:\nThe study arms mentioned in the model's output are fully included in the groundtruth study arm table. The model's output describes a \"Behavioral: Virtual Tai Chi Easy\" intervention, which is the same as the \"Experimental: Tai Chi Easy Intervention\" arm in the groundtruth study arm table. Both arms involve a virtual Tai Chi Easy intervention for a similar duration and frequency.\n\nSince the study arms from the model's output are present in the groundtruth study arm table, the match prediction is '1', indicating that the study arms are fully included in the groundtruth.",
            "Match prediction: 1\n\nExplanation:\nThe study arms mentioned in the model's output are fully included in the groundtruth study arm table. The model's output describes the \"Experimental: Tai Chi Easy Intervention\" arm, which matches the \"Experimental: Tai Chi Easy Intervention\" arm in the groundtruth study arm table. Both the participant group/arm and the intervention/treatment details are identical between the model's output and the groundtruth."
        ]
    },
    "NCT06062238": {
        "model_response": [
            "Alright. Now, let's discuss the criteria for the trial. Do you have any specific inclusion and exclusion criteria in mind?",
            "Of course! I'm here to help. If you have any more questions or need further assistance, feel free to ask. Good luck with your clinical trial!",
            "Thank you for the detailed exclusion criteria. Now, let's move on to the design details of the study. What is the primary purpose of this trial?",
            "Thank you for providing the design details. Based on the information you've provided, I suggest the following study arms:\n\nStudy Arms:\n1. Experimental: M72/AS01E-4 Mycobacterium tuberculosis investigational vaccine\n- Participant Group/Arm: Subjects receiving the Mtb candidate vaccine\n- Intervention/Treatment: Biological: M72/AS01E-4 Mycobacterium tuberculosis investigational vaccine\n- Administer: intradermal injection per dose schedule\n\n2. Placebo Comparator: Placebo for Comparator (saline solution)\n- Participant Group/Arm: Subjects receiving the placebo\n- Intervention/Treatment: Other: Saline solution\n- Administer: identical to active dose administration: intradermal injection per dose schedule",
            "That sounds good. Now, let's define the intervention/treatment for this arm. What participant group/arm and intervention/treatment do you suggest for this arm?",
            "This arm is crucial as it allows us to assess the efficacy and safety of the M72/AS01E-4 vaccine in comparison to the control arm. By administering the vaccine to recipients, we can evaluate the immune response generated in response to the vaccine and determine its potential in preventing or mitigating TB infection or disease progression.",
            "How about \"Placebo Comparator: Participants receiving saline\"?",
            "This arm serves as the control group to compare the outcomes of the placebo group to the vaccine group. By including a placebo arm, researchers can evaluate the specific effects of the M72/AS01E-4 vaccine on preventing tuberculosis in adolescents and adults.",
            "Perfect! You have successfully designed the study arms for the clinical trial. Well done!"
        ],
        "eval_results": [
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms or interventions. It is a general discussion about the criteria for the trial. The groundtruth study arm table, on the other hand, lists two experimental arms: one receiving the M72/AS01E-4 vaccine and the other receiving a placebo. Since the model output does not contain any information about these specific study arms, it cannot be evaluated as a match to the groundtruth study arm table. Therefore, the match prediction is 0, indicating that the study arms mentioned in the model's output are not present in the full table of groundtruth study arms.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms or interventions. It is a general statement about the clinical trial and does not provide any details about the study arms. \n\nIn contrast, the groundtruth study arm table clearly outlines two experimental arms: one receiving the M72/AS01E-4 investigational vaccine and the other receiving a placebo. The model output does not contain any information about these specific study arms, so it cannot be considered a match to the groundtruth study arm table.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms, it only asks about the primary purpose of the trial. The groundtruth study arm table shows two experimental arms: one receiving the M72/AS01E-4 vaccine and the other receiving a placebo. The study arms mentioned in the model output are not present in the groundtruth study arm table, so the match prediction is 0.",
            "Match prediction: 1\n\nExplanation:\nThe study arms mentioned in the model's output are fully included in the groundtruth study arm table. The model's output describes two study arms:\n\n1. Experimental: M72/AS01E-4 Mycobacterium tuberculosis investigational vaccine\n2. Placebo Comparator: Placebo for Comparator (saline solution)\n\nThese two study arms are present in the groundtruth study arm table, with the same participant groups/arms and intervention/treatment descriptions. The groundtruth table also provides additional details about the administration of the interventions, which aligns with the information provided in the model's output.\n\nTherefore, the study arms mentioned in the model's output are fully included in the groundtruth study arm table, and the match prediction is '1'.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms or interventions. It simply asks for suggestions on defining the participant group/arm and intervention/treatment. \n\nThe groundtruth study arm table, on the other hand, includes two experimental arms: one receiving the M72/AS01E-4 investigational vaccine and the other receiving a placebo. The model output does not contain any information about these specific study arms, so they are not present in the model's output.\n\nTherefore, the study arms mentioned in the model's output are not fully included in the groundtruth study arm table, and the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output mentions a \"control arm\" but does not provide any specific details about the intervention or treatment for this arm. The groundtruth study arm table, on the other hand, clearly defines two experimental arms: one receiving the M72/AS01E-4 vaccine and the other receiving a placebo (normal saline). The model output does not mention the placebo arm, which is a key component of the groundtruth study design. Therefore, the study arms mentioned in the model's output are not fully included in the groundtruth study arm table, and the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output mentions \"Placebo Comparator: Participants receiving saline\", but this study arm is not present in the provided groundtruth study arm table. The groundtruth table only includes an \"Experimental: Participants receiving placebo\" arm, where participants receive normal saline, and an \"Experimental: Participants receiving M72/AS01E-4\" arm, which does not match the \"Placebo Comparator\" arm mentioned in the model output. Therefore, the study arms mentioned in the model output are not fully included in the groundtruth study arm table, and the match prediction is 0.",
            "Match prediction: 1\n\nExplanation:\nThe model output mentions a \"placebo comparator arm\" which includes \"obese subjects with Type 2 Diabetes at risk of Nonalcoholic Steatohepatitis\" and will receive a \"placebo, which will be designed to mimic the appearance of the active treatment but will not contain any active drug.\"\n\nThe groundtruth study arm table includes an \"Experimental: Participants receiving placebo\" arm, which aligns with the placebo comparator arm described in the model output. The groundtruth table also includes an \"Experimental: Participants receiving M72/AS01E-4\" arm, which is the active treatment arm.\n\nTherefore, the study arms mentioned in the model's output are fully included in the groundtruth study arm table, and the match prediction is '1'.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any study arms that are present in the provided groundtruth study arm table. The model output discusses a placebo comparator arm for a study evaluating the drug HU6, while the groundtruth study arm table describes a clinical trial for an investigational tuberculosis vaccine M72/AS01E-4 and a placebo. Since the study arms mentioned in the model output are not present in the groundtruth study arm table, the match prediction is 0."
        ]
    },
    "NCT05816928": {
        "model_response": [
            "Got it. Do you have any specific phase for this trial?",
            "Understood. Now, let's discuss the criteria for inclusion and exclusion in this trial. Can you provide me with those details?",
            "Thank you for providing the criteria. Now, let's move on to the design details of the study. Do we have any specific design in mind?",
            "Certainly! The first study arm, COVID19-associated ARDS (CARDS), is essential because we want to specifically evaluate the effectiveness of prone positioning in COVID19-associated ARDS cases. By studying this group of patients separately, we can better understand the impact of proning on ventilation-perfusion matching in this specific population.\n\nThe second study arm, Non-COVID19-associated ARDS (non-CARDS), is important as well. While COVID19-associated ARDS has been extensively studied, there may be differences in the response to proning and its impact on oxygenation and ventilation-perfusion matching compared to non-COVID19-associated ARDS cases. By studying this group of patients separately, we can compare the effectiveness of prone positioning in COVID19-associated ARDS cases versus non-COVID19-associated ARDS cases and examine any differences or similarities in outcomes.",
            "Certainly! Here are the full study arms:\n\n1. Participant Group/Arm: COVID19-associated ARDS (CARDS)\n   Intervention/Treatment: Patients in this group are COVID19 patients with acute respiratory distress syndrome. They will be placed in the prone position while their pulmonary function is measured using EIT before and after proning.\n\n2. Participant Group/Arm: Non-COVID19-associated ARDS (non-CARDS)\n   Intervention/Treatment: Patients in this group have acute respiratory distress syndrome from other etiologies. They will be placed in the prone position while their pulmonary function is measured using EIT before and after proning."
        ],
        "eval_results": [
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms or interventions. It simply asks about the phase of the trial. The groundtruth study arm table, on the other hand, describes two participant groups/arms: \"COVID19-associated ARDS (CARDS)\" and \"Non-COVID19-associated ARDS (non-CARDS)\". These study arms are not mentioned in the model output. Therefore, the study arms mentioned in the model output are not present in the full table of groundtruth study arms, and the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms or interventions. It only asks for the details of the inclusion and exclusion criteria for the trial. The groundtruth study arm table, on the other hand, provides information about two study arms: COVID19-associated ARDS (CARDS) and Non-COVID19-associated ARDS (non-CARDS). These study arms are not mentioned in the model output. Therefore, the study arms mentioned in the model output are not present in the full table of groundtruth study arms, and the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms or interventions. It simply asks about the study design, without providing any details about the study arms or treatments.\n\nOn the other hand, the groundtruth study arm table lists two participant groups: \"COVID19-associated ARDS (CARDS)\" and \"Non-COVID19-associated ARDS (non-CARDS)\". These study arms are not mentioned in the model output.\n\nTherefore, the study arms mentioned in the model output are not present in the groundtruth study arm table, and the match prediction is 0.",
            "Match prediction: 1\n\nExplanation:\nThe model output accurately describes the two study arms present in the groundtruth study arm table: \n1. COVID19-associated ARDS (CARDS)\n2. Non-COVID19-associated ARDS (non-CARDS)\n\nThe model output correctly identifies these two study arms and provides a clear explanation for the purpose of each arm, which aligns with the information provided in the groundtruth study arm table. Therefore, the study arms mentioned in the model's output are fully included in the groundtruth study arm table, and the match prediction is 1.",
            "Match prediction: 1\n\nExplanation:\nThe study arms mentioned in the model's output are fully included in the groundtruth study arm table. The model's output accurately describes the two study arms:\n\n1. COVID19-associated ARDS (CARDS) - This arm is present in the groundtruth table, and the description matches the model's output.\n2. Non-COVID19-associated ARDS (non-CARDS) - This arm is also present in the groundtruth table, and the description matches the model's output.\n\nSince all the study arms mentioned in the model's output are present in the groundtruth study arm table, the match prediction is '1', indicating that the study arms from the model's output are fully included in the groundtruth."
        ]
    },
    "NCT05864144": {
        "model_response": [
            "Good question! Patients in Phase 1 dose expansion cohorts who receive SNS-101 as a monotherapy must have had at least 1 prior line of systemic therapy for metastatic disease. This helps to ensure that patients who have exhausted standard treatment options are included in the trial. Does that answer your question?",
            "That's a good idea. In Part B, patients will receive SNS-101 in combination with cemiplimab. The intervention will involve administering SNS-101 and cemiplimab on specific days of the cycle. The purpose of this arm is to evaluate the safety and efficacy of the combination therapy. Dose escalation will be performed in Phase 1 to determine the MTD or RP2D, and dose expansion will include both expansion cohort and cohorts with the RP2D. This arm aims to assess the potential synergistic effects of SNS-101 and cemiplimab in patients with advanced solid tumors. What are your thoughts on this study arm?",
            "Thank you for providing the full criteria. They are well-designed and comprehensive. If you have any more questions or need further assistance, feel free to ask!",
            "That's a great choice for the third study arm as well. In this arm, patients will be enrolled in cohorts based on histology of the tumor. The intervention will include SNS-101 IV, cemiplimab IV, or both as applicable. This arm will further evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of SNS-101 alone or in combination with cemiplimab in specific tumor types. It will help determine the potential benefit of the combination therapy in patients with advanced solid tumors. What are your thoughts on this study arm?",
            "Yes, you've provided the full criteria for the clinical trial based on our discussion. Well done! Let me know if you need any further assistance.",
            "Certainly! Here are the full study arms we have designed:\n\nStudy Arms:\n1. Experimental: Part A - SNS-101 Monotherapy Dose Escalation and Dose Expansion\n   - Participant Group/Arm: Patients with advanced solid tumors will receive SNS-101 as a monotherapy.\n   - Intervention/Treatment: SNS-101 (anti-VISTA) IV every 21 days.\n\n2. Experimental: Part B - SNS-101 in combination with cemiplimab and Dose Expansion\n   - Participant Group/Arm: Patients with advanced solid tumors will receive both SNS-101 and cemiplimab.\n   - Intervention/Treatment: SNS-101 IV and cemiplimab IV every 21 days.\n\n3. Experimental: Part C - Cohort Expansion - SNS-101 alone or in combination with cemiplimab\n   - Participant Group/Arm: Patients with advanced solid tumors will have the option to receive SNS-101 alone or in combination with cemiplimab.\n   - Intervention/Treatment: SNS-101 IV alone or in combination with cemiplimab IV every 21 days at the recommended phase 2 dose."
        ],
        "eval_results": [
            "Match prediction: 0\n\nExplanation:\nThe model output mentions \"Patients in Phase 1 dose expansion cohorts who receive SNS-101 as a monotherapy\", but this study arm is not explicitly described in the provided groundtruth study arm table. The groundtruth table includes three experimental arms, but none of them specifically mention a \"SNS-101 as a monotherapy\" arm. The closest arm is the \"Experimental: Part A - SNS-101 Monotherapy Dose Escalation and Dose Expansion\" arm, but this arm also includes dose escalation cohorts, which are not mentioned in the model output. Therefore, the study arms mentioned in the model output are not fully included in the groundtruth study arm table, and the match prediction is 0.",
            "Match prediction: 1\n\nExplanation:\nThe model output mentions the study arm \"Part B - SNS-101 in combination with cemiplimab and Dose Expansion\", which is fully included in the groundtruth study arm table. The groundtruth table clearly shows the \"Experimental: Part B - SNS-101 in combination with cemiplimab and Dose Expansion\" arm, which involves administering SNS-101 and cemiplimab every 21 days, with dose escalation and expansion phases. Therefore, the study arms mentioned in the model's output are present in the full table of groundtruth study arms, and the match prediction is 1.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms or interventions. It simply states that the study is well-designed and comprehensive, and offers to provide further assistance if needed. \n\nThe groundtruth study arm table, on the other hand, clearly outlines three different experimental arms:\n1. Part A - SNS-101 Monotherapy Dose Escalation and Dose Expansion\n2. Part B - SNS-101 in combination with cemiplimab and Dose Expansion\n3. Part C - Cohort Expansion - SNS-101 alone or in combination with cemiplimab\n\nSince the model output does not mention any of these specific study arms, it cannot be considered a match to the groundtruth study arm table. The study arms described in the model output are not present in the groundtruth table.",
            "Match prediction: 0\n\nExplanation:\nThe model output mentions a study arm with \"SNS-101 IV, cemiplimab IV, or both as applicable\", but this specific combination arm is not present in the groundtruth study arm table. The groundtruth table includes the following arms:\n\n1. Experimental: Part A - SNS-101 Monotherapy Dose Escalation and Dose Expansion\n2. Experimental: Part B - SNS-101 in combination with cemiplimab and Dose Expansion\n3. Experimental: Part C - Cohort Expansion - SNS-101 alone or in combination with cemiplimab\n\nWhile the groundtruth table does include arms with SNS-101 alone and SNS-101 in combination with cemiplimab, it does not have a specific arm for \"SNS-101 IV, cemiplimab IV, or both as applicable\" as mentioned in the model output. Therefore, the study arms from the model output are not fully included in the groundtruth study arm table, and the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms or interventions. It simply states that the full criteria for the clinical trial have been provided based on the previous discussion. However, the groundtruth study arm table shows the details of the different study arms, which include:\n\n1. Experimental: Part A - SNS-101 Monotherapy Dose Escalation and Dose Expansion\n2. Experimental: Part B - SNS-101 in combination with cemiplimab and Dose Expansion\n3. Experimental: Part C - Cohort Expansion - SNS-101 alone or in combination with cemiplimab\n\nThe model output does not contain any information about these specific study arms, so it cannot be considered a match to the groundtruth study arm table. The study arms mentioned in the model output are not present in the groundtruth table.",
            "Match prediction: 1\n\nExplanation:\nThe study arms mentioned in the model's output are fully included in the groundtruth study arm table. The model's output describes three study arms:\n\n1. Experimental: Part A - SNS-101 Monotherapy Dose Escalation and Dose Expansion\n2. Experimental: Part B - SNS-101 in combination with cemiplimab and Dose Expansion\n3. Experimental: Part C - Cohort Expansion - SNS-101 alone or in combination with cemiplimab\n\nAll of these study arms are present in the groundtruth study arm table, with the same participant group/arm names and intervention/treatment details. Therefore, the study arms mentioned in the model's output are fully included in the groundtruth study arm table, and the match prediction is 1."
        ]
    },
    "NCT05783973": {
        "model_response": [
            "Alright. Now, let's discuss the criteria for participant selection. Can you provide me with the inclusion criteria?",
            "That makes sense. By excluding these patients, we can obtain more homogeneous results. Now, let's move on to the design details of your study. Do you have any specific study arms in mind?",
            "That sounds reasonable. Let's start with Study Arm 1. What participant group/arm will be included in this arm, and what intervention/treatment will be provided?",
            "Perfect! Now, what intervention or treatment would you like to assign to the \"bile group\"?",
            "Excellent! The intervention or treatment will involve performing NGS to analyze genetic alterations in bile, tissue, and tissue samples. This will provide valuable data for assessing the feasibility and effectiveness of using bile cfDNA as a biomarker for BTC. Now, let's move on to the second study arm. Who would you like to include in this arm?",
            "Good choice. The \"tissue group\" involves collecting tissue samples from resectable BTC patients and performing 520 Panel sequencing. This will serve as a control group to assess the reliability of bile cfDNA as a non-invasive source compared to traditional tissue sampling. What intervention or treatment should be provided in this arm?",
            "Excellent! Now let's discuss the third study arm. What participant group or arm would you like to include in this arm?",
            "That's a good choice. The \"plasma group\" involves collecting plasma samples from resectable BTC patients and conducting 520 Panel sequencing. This will allow us to assess the feasibility of using plasma cfDNA for ctDNA analysis in BTC. Now, what intervention or treatment should be provided in this arm?",
            "Fantastic! Based on the information you provided, here are the full study arms for your trial:\n\nStudy Arm 1: Bile group\n- Participant Group/Arm: Patients with resectable BTC with at least one biliary tract accessible sample\n- Intervention/Treatment: Diagnostic Test - Next Generation Sequencing (NGS)\n\nStudy Arm 2: Tissue group\n- Participant Group/Arm: Patients with resectable BTC in need of a surgical resection\n- Intervention/Treatment: Diagnostic Test - Next Generation Sequencing (NGS)\n\nStudy Arm 3: Plasma group\n- Participant Group/Arm: Patients with resectable BTC\n- Intervention/Treatment: Diagnostic Test - Next Generation Sequencing (NGS)"
        ],
        "eval_results": [
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any of the study arms present in the groundtruth study arm table. The groundtruth table describes three study arms: bile group, tissue group, and plasma group, all of which involve next-generation sequencing of bile, tissue, and plasma samples from patients with resectable biliary tract cancer (BTC). However, the model output does not discuss these specific study arms or interventions. Instead, it asks about the inclusion criteria, which is not directly related to the study arms described in the groundtruth table. Therefore, the study arms mentioned in the model output are not present in the groundtruth study arm table, and the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms. It only asks if the researcher has any specific study arms in mind. The groundtruth study arm table, on the other hand, lists three study arms: bile group, tissue group, and plasma group. These study arms are not mentioned in the model output, so the study arms from the model's output are not fully included in the groundtruth study arm table. Therefore, the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms that can be matched to the groundtruth study arm table provided. The groundtruth table describes three study arms: bile group, tissue group, and plasma group, all of which involve next-generation sequencing of bile, tissue, and plasma samples from patients with resectable biliary tract cancer (BTC). However, the model output does not reference any of these study arms or interventions. Therefore, the study arms mentioned in the model output are not present in the full table of groundtruth study arms, and the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms. It simply asks about assigning an intervention or treatment to the \"bile group\". However, the groundtruth study arm table does not contain a \"bile group\" as a participant group/arm. Instead, the table lists three different groups: \"bile group\", \"Tissue group\", and \"Plasma group\", all of which are related to diagnostic tests using next-generation sequencing. Since the model output does not refer to any of the study arms present in the groundtruth table, the match prediction is 0, indicating that the study arms mentioned in the model's output are not included in the groundtruth study arm table.",
            "Match prediction: 1\n\nExplanation:\nThe model output mentions the study arm involving \"performing NGS to analyze genetic alterations in bile, tissue, and tissue samples\". This study arm is fully included in the groundtruth study arm table, which lists the following arms:\n\n1. \"bile group\" - Performing NGS on bile samples from 20 resectable BTC patients.\n2. \"Tissue group\" - Performing NGS on tissue samples from 20 resectable BTC patients.\n3. \"Plasma group\" - Performing NGS on plasma samples from 20 resectable BTC patients.\n\nThe model output's description of the study arm is consistent with the groundtruth study arm table, and all the key elements (NGS, bile, tissue, and tissue samples) are present in the groundtruth. Therefore, the study arms mentioned in the model's output are fully included in the groundtruth study arm table, and the match prediction is '1'.",
            "Match prediction: 1\n\nExplanation:\nThe model output mentions the \"tissue group\" which involves collecting tissue samples from resectable BTC patients and performing 520 Panel sequencing. This matches the \"Tissue group\" arm in the groundtruth study arm table, which also involves collecting tissue samples from resectable BTC patients and performing 520 Panel sequencing.\n\nThe groundtruth study arm table includes three arms: the \"bile group\", the \"Tissue group\", and the \"Plasma group\". The model output specifically refers to the \"tissue group\", which is fully included in the groundtruth study arm table. Therefore, the study arms mentioned in the model's output are present in the full table of groundtruth study arms, and the match prediction is 1.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms that can be matched to the groundtruth study arm table provided. The model output is asking about a third study arm, but the groundtruth table only contains information about three different participant groups/arms: bile group, tissue group, and plasma group. None of these arms match the description in the model output, which is asking about a different study arm. Therefore, the study arms mentioned in the model's output are not present in the full table of groundtruth study arms, and the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output mentions a \"plasma group\" that involves collecting plasma samples from resectable BTC patients and conducting 520 Panel sequencing. However, the groundtruth study arm table does not contain a \"plasma group\" with the same intervention or treatment. The groundtruth table only includes a \"Plasma group\" that involves collecting plasma samples from 20 resectable BTC patients with 520 Panel sequencing (plasma 10000X), which is not exactly the same as the \"plasma group\" mentioned in the model output.\n\nTherefore, the study arms mentioned in the model's output are not fully included in the groundtruth study arm table, and the match prediction is 0.",
            "Match prediction: 1\n\nExplanation:\nThe study arms mentioned in the model's output are fully included in the groundtruth study arm table. The model's output describes three study arms:\n\n1. Bile group\n2. Tissue group \n3. Plasma group\n\nThese three study arms are all present in the groundtruth study arm table, with the same participant group/arm descriptions and the same intervention/treatment of \"Diagnostic Test - Next Generation Sequencing (NGS)\".\n\nTherefore, the study arms mentioned in the model's output are fully included in the groundtruth study arm table, and the match prediction is 1."
        ]
    },
    "NCT05790967": {
        "model_response": [
            "Thank you for the information. Could you please tell me the study type and phase?",
            "And what is the phase of your study?",
            "Understood. Now, let's move on to the design details. Can you provide me with the allocation and intervention model?",
            "Yes, excluding participants under treatment with antidepressants is a necessary step to ensure the integrity of the study results. This will help minimize potential confounding factors related to antidepressant use during pregnancy.",
            "Wonderful! Now that we have designed the study arms, let's summarize them:\n\nStudy Arms:\n\n1. Experimental: Education Group\n- Participant Group/Arm: Pregnant women in the education group\n- Intervention/Treatment: Sexual Education\n- Two hours of individual and face-to-face training with homework assignments and information booklet to support this\n\n2. No Intervention: CONTROL\n- Participant Group/Arm: Pregnant women in the control group\n- Intervention/Treatment: None\n- Other routine procedures"
        ],
        "eval_results": [
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms. It only asks for the study type and phase, which is not provided in the given groundtruth study arm table. The groundtruth table includes two study arms: \"Experimental: Education Group\" and \"No Intervention: CONTROL\", which are not mentioned in the model output. Therefore, the study arms mentioned in the model output are not present in the full table of groundtruth study arms, and the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms. It only asks about the phase of the study, which is not provided in the groundtruth study arm table. The groundtruth study arm table includes two arms: \"Experimental: Education Group\" and \"No Intervention: CONTROL\", which are not mentioned in the model output. Therefore, the study arms mentioned in the model output are not present in the full table of groundtruth study arms, and the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms or interventions. It only asks for the allocation and intervention model, without providing any details about the study arms.\n\nThe groundtruth study arm table, on the other hand, lists two study arms: \"Experimental: Education Group\" and \"No Intervention: CONTROL\". These study arms are not mentioned in the model output, so the study arms from the model output are not fully included in the groundtruth study arm table.\n\nTherefore, the match prediction is 0, as the study arms mentioned in the model output are not present in the groundtruth study arm table.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms. It discusses the necessity of excluding participants on antidepressants, but does not provide any information about the study arms present in the groundtruth study arm table. The groundtruth study arm table includes two arms: \"Experimental: Education Group\" and \"No Intervention: CONTROL\", which are not mentioned in the model output. Therefore, the study arms mentioned in the model output are not present in the groundtruth study arm table, and the match prediction is 0.",
            "Match prediction: 1\n\nExplanation:\nThe study arms mentioned in the model's output are fully included in the groundtruth study arm table. The model's output describes two study arms:\n\n1. Experimental: Education Group\n2. No Intervention: CONTROL\n\nThese two study arms are present in the groundtruth study arm table, with the same participant group/arm names and intervention/treatment descriptions. Therefore, the study arms from the model's output are fully included in the groundtruth study arm table, and the match prediction is '1'."
        ]
    },
    "NCT05946837": {
        "model_response": [
            "Thank you for providing those details. It seems like you have a well-designed intervention/treatment plan. Now, let's move on to the study type and phase. Can you please provide me with that information?",
            "Great! Now, let's move on to the design of the study arms. Based on the information you provided, I would recommend having two study arms. The first arm will focus on individuals with neck pain, while the second arm will include subjects with back pain. This will allow us to draw comparisons and evaluate whether PCT delivered by a pneumatic manual lymphatic drainage device is equally effective for different pain conditions. What do you think?",
            "Thank you for providing the criteria. Now, let's discuss the study arms. Based on the information you've provided, we can design the following study arms:\n\n1. Study Arm D: Experimental: NIRF-LI Imaging (750\u03bcg of ICG) (drug)/placebo (Neuroglide pad)\n- Participants will receive 30 injections of ICG, followed by NIRF-LI imaging. They will then lie down on the Neuroglide pad during the one-hour Pneumatic Compression Therapy (PCT) treatment session.\n\n2. Study Arm F: Experimental: PCT Treatment\n- Participants will lie down on the Neuroglide pad during the one-hour Pneumatic Compression Therapy (PCT) treatment session.\n\n3. Study Arm H: Placebo: 750\u03bcg of ICG (Neuroglide pad)\n- Participants will receive a saline solution injection with no other intervention."
        ],
        "eval_results": [
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms or interventions. It only asks for information about the study type and phase. The groundtruth study arm table, on the other hand, describes an experimental arm involving Pneumatic Compression Therapy (PCT) with Indocyanine green (ICG) dye, NIRF-LI imaging, and a Neuroglide pad. None of these study arms or interventions are mentioned in the model output. Therefore, the study arms mentioned in the model output are not present in the groundtruth study arm table, and the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output mentions two study arms: one for individuals with neck pain and another for individuals with back pain. However, the groundtruth study arm table does not contain any information about these study arms. The groundtruth table only describes a single study arm that involves Pneumatic Compression Therapy (PCT) using a Neuroglide pad and Indocyanine green (ICG) dye for near-infrared fluorescence lymphatic imaging (NIRF-LI). There is no mention of study arms for neck pain or back pain in the groundtruth information provided. Therefore, the study arms described in the model output are not present in the groundtruth study arm table, and the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\n\nThe model output mentions three study arms:\n\n1. Study Arm D: Experimental: NIRF-LI Imaging (750\u03bcg of ICG) (drug)/placebo (Neuroglide pad)\n2. Study Arm F: Experimental: PCT Treatment\n3. Study Arm H: Placebo: 750\u03bcg of ICG (Neuroglide pad)\n\nHowever, the groundtruth study arm table only includes a single arm, which is the \"Experimental: Pneumatic Compression Therapy (PCT)\" arm. This arm includes the use of Indocyanine green (ICG) dye, NIRF-LI imaging, and the Neuroglide pad, but it does not match the specific study arms mentioned in the model output.\n\nThe groundtruth study arm table does not contain the details about the \"Placebo: 750\u03bcg of ICG (Neuroglide pad)\" arm or the \"Experimental: PCT Treatment\" arm mentioned in the model output. Therefore, the study arms described in the model output are not fully included in the groundtruth study arm table."
        ]
    },
    "NCT06083090": {
        "model_response": [
            "That's a valid point. By excluding participants who have recently received other treatments, we can focus on evaluating the specific effects of yoga therapy and physiotherapy. Now, let's move on to the design details of your study. Could you provide me with some information about allocation, intervention model, and masking?",
            "Alright. What type of allocation and intervention model do you have in mind?",
            "Perfect. And what kind of intervention model and masking strategy will you be using?",
            "Thank you for providing all the necessary details. Based on the information you've given me, I have designed two study arms for your clinical trial. The first study arm will include participants who will undergo 18 sessions of hot yoga therapy over six weeks. The second study arm will include participants who will undergo 18 sessions of physiotherapy over six weeks.",
            "I'm glad you find them suitable. These study arms will help us evaluate the effectiveness of yoga therapy in managing axial spondyloarthritis symptoms. If you have any further questions or need assistance with anything else, feel free to ask."
        ],
        "eval_results": [
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms or interventions. It is a general discussion about the study design, including allocation, intervention model, and masking. The groundtruth study arm table, on the other hand, clearly defines two study arms: \"Experimental: Yogatherapy\" and \"Active Comparator: Physiotherapy\". These study arms are not mentioned in the model output, so the study arms from the model output are not present in the groundtruth study arm table. Therefore, the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms or interventions. It simply asks about the type of allocation and intervention model. The groundtruth study arm table, on the other hand, clearly outlines two study arms: \"Experimental: Yogatherapy\" and \"Active Comparator: Physiotherapy\". These study arms are not mentioned in the model output, so the study arms from the model output are not fully included in the groundtruth study arm table. Therefore, the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms or interventions. It only asks about the intervention model and masking strategy. The groundtruth study arm table, on the other hand, describes two study arms: \"Experimental: Yogatherapy\" and \"Active Comparator: Physiotherapy\". These study arms are not mentioned in the model output. Therefore, the study arms mentioned in the model output are not present in the full table of groundtruth study arms, and the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output mentions two study arms: \"Hot yoga therapy\" and \"Physiotherapy\", which are not present in the groundtruth study arm table. The groundtruth study arm table includes \"Yogatherapy\" and \"Physiotherapy\" as the study arms, which do not match the arms mentioned in the model output. Therefore, the study arms mentioned in the model's output are not fully included in the groundtruth study arm table, and the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms that can be matched to the groundtruth study arm table. The model output talks about evaluating the effectiveness of yoga therapy in managing axial spondyloarthritis symptoms, but it does not provide any details about the study arms. \n\nOn the other hand, the groundtruth study arm table clearly defines two study arms: \"Experimental: Yogatherapy\" and \"Active Comparator: Physiotherapy\". These study arms are not mentioned in the model output, and therefore, the study arms from the model output cannot be fully included in the groundtruth study arm table."
        ]
    },
    "NCT06160986": {
        "model_response": [
            "Thank you for the information. Now, let's move on to the design details. Can you tell me the primary purpose, allocation, intervention model, and masking of your trial?",
            "Thank you for clarifying that. Now, let's proceed to the design details. What is the primary purpose of your study?",
            "Certainly! The Horizons Group arm will consist of patients with chronic graft vs host disease who have received an allogeneic hematopoietic stem cell transplant. If their condition meets the criteria for being moderate to severe, they will be approached to participate in the intervention. These patients will initially receive the standard individual education session by a member of the BMT Psychosocial team. They will then have video conferences with the Horizons Group for 8 sessions, where they can interact with each other and receive the intervention.",
            "We don't have any additional study arms planned at the moment. The Horizons Group arm focuses on the specific goals and interventions we aim to evaluate in this trial. However, if you have any specific ideas or suggestions for additional study arms, I'm all ears!",
            "Based on the goals of the trial, it would be beneficial to have a control group that receives standard care without the intervention to serve as a comparison. This will allow us to evaluate the effectiveness of the Horizons Group intervention by observing any differences in outcomes between the intervention group and the control group. What do you think about adding a control group?",
            "Great! Here are the full study arms for your trial:\n\nStudy Arms:\n1. Experimental: Horizons Group\n   - Participant Group/Arm: Allogeneic adult hematopoietic stem cell transplantation patients with chronic graft-versus-host disease\n   - Intervention/Treatment: 8 weekly group sessions led by a clinician and a behavioral health specialist, covering state-of-the-science information about survivorship and chronic graft versus host disease, self-management strategies, access to an intervention manual, and audio-recorded relaxation exercises.\n\n2. No Intervention: Control\n   - Participant Group/Arm: Allogeneic adult hematopoietic stem cell transplantation patients with chronic graft-versus-host disease\n   - Intervention/Treatment: None\n\n3. Experimental: Modified\n   - Participant Group/Arm: Allogeneic adult hematopoietic stem cell transplantation patients with chronic graft-versus-host disease\n   - Intervention/Treatment: 4 weekly group sessions led by a clinician and a behavioral health specialist, covering state-of-the-science information about survivorship and chronic graft versus host disease, self-management strategies, access to an intervention manual, and audio-recorded relaxation exercises."
        ],
        "eval_results": [
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any study arms that are present in the provided groundtruth study arm table. The groundtruth table describes a single study arm called \"Experimental: Horizons Group\" which involves a behavioral intervention, while the model output does not provide any information about study arms or interventions. Therefore, the study arms mentioned in the model output are not present in the groundtruth study arm table, and the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any study arms that are present in the provided groundtruth study arm table. The model output is a general question about the primary purpose of the study, while the groundtruth study arm table describes an intervention called the \"Horizons Group Intervention\" for participants. There is no overlap between the study arms mentioned in the model output and the groundtruth study arm table, so the match prediction is 0, indicating that the study arms from the model output are not included in the groundtruth study arm table.",
            "Match prediction: 1\n\nExplanation:\nThe model output accurately describes the study arm mentioned in the groundtruth study arm table. The model output mentions the \"Horizons Group\" arm, which is the same as the \"Experimental: Horizons Group\" arm in the groundtruth table. The details provided in the model output, such as the participants being patients with chronic graft vs host disease who have received an allogeneic hematopoietic stem cell transplant, and the intervention involving 8 video conference sessions, match the information in the groundtruth table. Therefore, the study arms mentioned in the model's output are fully included in the groundtruth study arm table.",
            "Match prediction: 1\n\nExplanation:\nThe model output does not mention any specific study arms, but rather indicates that there are no additional study arms planned at the moment. The groundtruth study arm table, on the other hand, clearly describes a single study arm called \"Experimental: Horizons Group\", which includes the Horizons Group intervention as the intervention/treatment.\n\nSince the model output does not contradict or omit any of the study arms present in the groundtruth study arm table, the study arms mentioned in the model's output are fully included in the groundtruth study arm table. Therefore, the match prediction is 1, indicating that the study arms from the model's output are present in the full table of groundtruth study arms.",
            "Match prediction: 0\n\nExplanation:\nThe model output suggests adding a control group to the study, but the groundtruth study arm table does not contain any information about a control group. The groundtruth table only describes the \"Experimental: Horizons Group\" arm, which receives the Horizons Group intervention. There is no mention of a control group that receives standard care without the intervention. Therefore, the study arms mentioned in the model's output are not present in the full table of groundtruth study arms, and the match prediction is 0.",
            "Match prediction: 1\n\nExplanation:\nThe study arms mentioned in the model's output are fully included in the groundtruth study arm table. The model's output describes three study arms:\n\n1. Experimental: Horizons Group\n2. No Intervention: Control\n3. Experimental: Modified\n\nThe groundtruth study arm table includes the \"Experimental: Horizons Group\" arm, which matches the first arm described in the model's output.\n\nThe other two arms mentioned in the model's output (\"No Intervention: Control\" and \"Experimental: Modified\") are not present in the groundtruth study arm table. However, the presence of the \"Experimental: Horizons Group\" arm, which is fully described in the groundtruth table, is sufficient to conclude that the study arms mentioned in the model's output are present in the full table of groundtruth study arms.\n\nTherefore, the match prediction is '1', indicating that the study arms mentioned in the model's output are fully included in the groundtruth study arm table."
        ]
    },
    "NCT05718817": {
        "model_response": [
            "For the second study arm, we can consider having an experimental group receiving a higher dose of XEN1101. This arm can receive a fixed dose of 35 mg per day of XEN1101. This arm will help us evaluate the safety, tolerability, pharmacokinetics, and efficacy of a higher dose compared to the standard dose. We can label this arm as \"Experimental: XEN1101 35 mg/day\" with the intervention/treatment being \"Drug: XEN1101 - XEN1101 capsules\". This will allow us to compare the outcomes and potential benefits of a higher dose against the standard dose.",
            "Excellent! Based on our discussion, the full study arms for your clinical trial are as follows:\n\nStudy Arms:\n1. Participant Group/Arm: Experimental: XEN1101 25 mg/day\n   Intervention/Treatment: Drug: XEN1101 - XEN1101 capsules 25 mg per day\n\n2. Participant Group/Arm: Experimental: XEN1101 25 mg/day\n   Intervention/Treatment: Drug: XEN1101 - XEN1101 capsules 25 mg per day\n\nThese study arms will allow us to evaluate the safety, tolerability, pharmacokinetics, and efficacy of XEN1101 in individuals with focal epilepsy and primary generalized tonic-clonic seizures. Is there anything else I can assist you with?"
        ],
        "eval_results": [
            "Match prediction: 0\n\nExplanation:\nThe model output mentions a study arm \"Experimental: XEN1101 35 mg/day\", which is not present in the groundtruth study arm table. The groundtruth table only includes an arm for \"Experimental: XEN1101 25 mg/day\", which is a different dose compared to the one mentioned in the model output. Since the specific study arm mentioned in the model output is not present in the groundtruth table, the match prediction is 0, indicating that the study arms from the model's output are not fully included in the groundtruth study arm table.",
            "Match prediction: 1\n\nExplanation:\nThe study arms mentioned in the model's output are fully included in the groundtruth study arm table. The model's output lists two study arms:\n\n1. Participant Group/Arm: Experimental: XEN1101 25 mg/day\n   Intervention/Treatment: Drug: XEN1101 - XEN1101 capsules 25 mg per day\n\n2. Participant Group/Arm: Experimental: XEN1101 25 mg/day\n   Intervention/Treatment: Drug: XEN1101 - XEN1101 capsules 25 mg per day\n\nThese two study arms are present in the groundtruth study arm table, which lists a single study arm with the same participant group/arm and intervention/treatment details.\n\nTherefore, the study arms mentioned in the model's output are fully included in the groundtruth study arm table, and the match prediction is '1'."
        ]
    },
    "NCT05766917": {
        "model_response": [
            "Understood. Now, could you please provide me with the criteria for participant inclusion and exclusion in your trial?",
            "Thank you for providing the detailed criteria. Now, let's move on to the design details of the study. Could you tell me about the primary purpose, allocation, intervention model, and masking?",
            "Got it. How do you plan to allocate participants to the different study arms?",
            "Alright. What type of intervention model and masking are you considering?",
            "Excellent choice. Lastly, will the study be single or double-blinded?",
            "Thank you for all the information. Based on the details you provided, I can help you design the study arms. We have two study arms: the Experimental arm (Peer Educators Intervention) and the No Intervention arm (Usual Care).",
            "That's a good point. We can add a description to specify the type of peer education provided in the experimental group. How about this: \"The peer education in this arm will consist of two sessions, 45 minutes each, performed 48 hours after the patient's admission.\" This will ensure that the patients in the experimental group receive the intervention at a specific timeframe. What do you think?",
            "You're welcome! Here are the full study arms we have designed:\n\nStudy Arms:\n1. No Intervention: control group\nParticipant Group/Arm: Patients admitted to the burn units of a tertiary referral burns center in the Middle East.\nIntervention/Treatment: Patients in this group will receive routine hospital care provided in the burn center.\n\n2. Experimental: peer education group\nParticipant Group/Arm: Patients admitted to the burn units of a tertiary referral burns center in the Middle East.\nIntervention/Treatment: Patients in this group will receive routine hospital care along with peer education by trained peers."
        ],
        "eval_results": [
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms or interventions. It only asks for the criteria for participant inclusion and exclusion in the trial. The groundtruth study arm table, on the other hand, describes two study arms: a control group that receives routine hospital care, and an experimental group that receives routine hospital care plus a peer education intervention. \n\nSince the model output does not provide any information about the study arms, it cannot be evaluated against the groundtruth study arm table. The study arms mentioned in the model output are not present in the groundtruth table, so the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms that can be matched to the groundtruth study arm table provided. The model output is asking for more details about the study design, such as the primary purpose, allocation, intervention model, and masking, but it does not provide any information about the study arms themselves.\n\nThe groundtruth study arm table, on the other hand, describes two study arms: a \"No Intervention: control group\" and an \"Experimental: peer education group\". These study arms are not mentioned in the model output, and therefore, the study arms from the model output cannot be fully included in the groundtruth study arm table.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms, it only asks a general question about how participants will be allocated to the different study arms. The groundtruth study arm table, on the other hand, lists two study arms: a \"No Intervention: control group\" and an \"Experimental: peer education group\". The study arms mentioned in the model output are not present in the groundtruth study arm table, so the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms or interventions. It only asks about the type of intervention model and masking being considered.\n\nThe groundtruth study arm table, on the other hand, lists two study arms: a \"No Intervention: control group\" and an \"Experimental: peer education group\" where the intervention is a \"Behavioral: peer education group\".\n\nSince the model output does not provide any information about the study arms, it cannot be evaluated against the groundtruth study arm table. The study arms mentioned in the model output are not present in the groundtruth table, so the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any study arms that are present in the provided groundtruth study arm table. The groundtruth table includes a \"No Intervention: control group\" and an \"Experimental: peer education group\", which are not mentioned in the model output. Therefore, the study arms mentioned in the model output are not fully included in the groundtruth study arm table, and the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output mentions two study arms: \"Experimental arm (Peer Educators Intervention)\" and \"No Intervention arm (Usual Care)\". However, the groundtruth study arm table does not contain these exact study arm names. \n\nThe groundtruth study arm table has the following arms:\n1. \"No Intervention: control group\" \n2. \"Experimental: peer education group\"\n\nWhile the \"Experimental: peer education group\" arm seems to match the \"Experimental arm (Peer Educators Intervention)\" mentioned in the model output, the \"No Intervention: control group\" does not exactly match the \"No Intervention arm (Usual Care)\" from the model output.\n\nTherefore, the study arms mentioned in the model output are not fully included in the groundtruth study arm table, and the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms. It only describes the peer education intervention provided in the experimental group. However, the groundtruth study arm table does not contain the details provided in the model output. The groundtruth table only mentions a \"control group\" and an \"experimental: peer education group\", but does not provide the specific details about the duration and timing of the peer education sessions as described in the model output. Therefore, the study arms mentioned in the model output are not fully included in the groundtruth study arm table, and the match prediction is 0.",
            "Match prediction: 1\n\nExplanation:\nThe study arms mentioned in the model's output are fully included in the groundtruth study arm table. The model's output lists two study arms:\n\n1. No Intervention: control group\n2. Experimental: peer education group\n\nThese two study arms are present in the groundtruth study arm table, with the same participant group/arm descriptions and intervention/treatment details. Therefore, the study arms from the model's output are fully included in the groundtruth study arm table, and the match prediction is '1'."
        ]
    },
    "NCT06205238": {
        "model_response": [
            "Certainly! Here are the full study arms:\n\n1. Experimental: Domiciliary CGA\n- Participant Group/Arm: Frail older adults over the age of 75 discharged from the Emergency Department and referred to the Community Specialist Team in Limerick who have not received any CGA at the point of referral.\n- Intervention/Treatment: Comprehensive Geriatric Assessment delivered via domiciliary care, with nursing, medical, and allied health assessment and intervention provided in the patient's own home.\n- Reasoning: This arm aims to assess the impact of providing CGA in a home-based setting to frail older adults, which may improve patient comfort, accessibility, and overall outcomes.\n\n2. Active Comparator: Hub-based CGA\n- Participant Group/Arm: Frail older adults over the age of 75 discharged from the Emergency Department and referred to the Community Specialist Team in Limerick who have not received any CGA at the point of referral.\n- Intervention/Treatment: Comprehensive Geriatric Assessment delivered via hub-based care at an out-patient setting.\n- Reasoning: This arm serves as the comparison group to the hub-based CGA, allowing for the evaluation of the effectiveness of domiciliary CGA compared to hub-based CGA."
        ],
        "eval_results": [
            "Match prediction: 1\n\nExplanation:\nThe model output accurately describes the two study arms present in the groundtruth study arm table:\n\n1. Experimental: Domiciliary CGA\n   - The model output describes this arm as \"Experimental: Domiciliary CGA\" with the same participant group/arm and intervention/treatment details as in the groundtruth table.\n\n2. Active Comparator: Hub-based CGA\n   - The model output describes this arm as \"Active Comparator: Hub-based CGA\" with the same participant group/arm and intervention/treatment details as in the groundtruth table.\n\nThe study arms mentioned in the model output are fully included in the groundtruth study arm table, so the match prediction is 1."
        ]
    },
    "NCT06205836": {
        "model_response": [
            "Got it. And what is the study type and phase of your clinical trial?",
            "Perfect! Now, let's move on to the criteria. Could you please provide the key criteria for inclusion and exclusion?",
            "That criterion seems reasonable to me. It will help ensure that the study focuses on treatment-naive patients.",
            "Thank you for providing those details. Now, let's discuss the study arm designs. The first study arm is \"Study Arm A: Treatment with Cemiplimab (350 mg IV Q2W)\". The participant group/arm for this arm is \"Participants who will receive cemiplimab treatment.\" The intervention/treatment for this arm includes \"Drug: Cemiplimab\" administered IV at a dose of 350 mg every 2 weeks. This arm is necessary as it represents the standard treatment arm for the study. By including a treatment arm with cemiplimab alone, researchers can assess the efficacy of cemiplimab monotherapy in this population. This arm will provide valuable information about the response rate and progression-free survival of cemiplimab treatment in older patients with localized or locally advanced MSI-H colorectal cancer. Any suggestions or concerns about this arm?",
            "Great! The first study arm is the active comparator arm, which involves the use of cemiplimab alone. The treatment for this arm is cemiplimab, administered intravenously at a dose of 350 milligrams every three weeks for up to 32 doses. The purpose of this arm is to assess the efficacy and safety of cemiplimab as a single treatment option in elderly patients with MSI-H colorectal cancer. What are your thoughts on this arm?",
            "Absolutely! Now, let's move on to the second study arm. This arm is the experimental cohort B. The participant group/arm consists of patients who will receive cemiplimab and fianlimab as the treatment. Fianlimab is also administered on Day 1 of each 21-day cycle for a total of 4 cycles, similar to cemiplimab. The dosage for cemiplimab and fianlimab is 350 mg and 8mg/kg IV, respectively. What do you think about including this arm in the study?",
            "The second study arm is the experimental cohort B. The participant group/arm consists of patients who will receive a combination of cemiplimab and fianlimab. The intervention/treatment for this arm is cemiplimab (350 mg administered IV) on Day 1 of each 21-day cycle for a total of 4 cycles of treatment, along with fianlimab (900 mg administered IV) on Day 1 of each 21-day cycle for a total of 6 cycles of treatment. The other names for cemiplimab are REGN2810 and LIBTAYO, while fianlimab is administered as SAR439091. This arm is crucial to evaluate the combination therapy of cemiplimab and fianlimab in treating microsatellite unstable localized or locally advanced colorectal cancer in older patients. By comparing the outcomes of this arm with the monotherapy arm, the researchers can determine if the combination treatment is more effective or tolerable compared to cemiplimab alone. What are your thoughts on this arm?",
            "I completely agree. Now that we have designed both study arms, let me summarize them for you.\n\nStudy Arms:\n1. Experimental: Cohort A\n   - Participant Group/Arm: Patients who will receive cemiplimab as the sole treatment.\n   - Intervention/Treatment: Cemiplimab (350 mg administered IV) on Day 1 of each 21-day cycle for a total of 4 cycles of treatment (REGN2810, LIBTAYO).\n\n2. Experimental: Cohort B\n   - Participant Group/Arm: Patients who will receive both cemiplimab and fianlimab in combination.\n   - Intervention/Treatment: Cemiplimab (350 mg administered IV) on Day 1 of each 21-day cycle for a total of 4 cycles of treatment (REGN2810, LIBTAYO). Fianlimab (1600 mg administered IV) on Day 1 of each 21-day cycle for a total of 4 cycles of treatment (REGN3767).\n\nPlease let me know if you need any further assistance or if you have any other questions."
        ],
        "eval_results": [
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms or interventions. It only asks about the study type and phase of the clinical trial. The groundtruth study arm table, on the other hand, describes two experimental arms: \"Cohort A - Cemiplimab\" and \"Cohort B - Cemiplimab with Fianlimab\". These study arms are not present in the model output, so the study arms mentioned in the model's output are not fully included in the groundtruth study arm table. Therefore, the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any study arms that are present in the provided groundtruth study arm table. The model output discusses a placebo comparator arm for a drug called \"HU6\", but this arm is not present in the groundtruth study arm table, which only includes information about the experimental arms for the drugs Cemiplimab and Fianlimab. Therefore, the study arms mentioned in the model's output are not fully included in the groundtruth study arm table, and the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms or interventions. It only discusses the general criteria of focusing on treatment-naive patients. The groundtruth study arm table, on the other hand, describes two experimental arms: one with Cemiplimab and another with Cemiplimab and Fianlimab. Since the model output does not contain any information about the specific study arms mentioned in the groundtruth, I cannot conclude that the study arms from the model output are fully included in the groundtruth study arm table. Therefore, the match prediction is 0.",
            "Match prediction: 1\n\nExplanation:\nThe study arm mentioned in the model output, \"Study Arm A: Treatment with Cemiplimab (350 mg IV Q2W)\", is fully included in the groundtruth study arm table. The groundtruth table has an \"Experimental: Cohort A - Cemiplimab\" arm, which describes the same intervention of administering Cemiplimab (350 mg IV) every 2 weeks. The details provided in the model output match the information in the groundtruth study arm table, indicating that the study arm from the model output is present in the groundtruth.",
            "Match prediction: 1\n\nExplanation:\nThe study arms mentioned in the model's output, specifically the \"Experimental: Active Treatment: HU6\" and \"Placebo Comparator: Placebo Comparator\" arms, are fully included in the groundtruth study arm table. The groundtruth table contains the details of the \"Experimental: Active Treatment: HU6\" arm, which involves the use of the drug HU6, and the \"Placebo Comparator: Placebo Comparator\" arm, which involves the use of a placebo. Therefore, the study arms from the model's output are present in the groundtruth study arm table, and the match prediction is '1'.",
            "Match prediction: 1\n\nExplanation:\nThe model output mentions the \"Experimental: Cohort B - Cemiplimab with Fianlimab\" study arm, which is fully present in the groundtruth study arm table. The groundtruth table clearly describes this arm, including the interventions of Cemiplimab (350 mg IV) and Fianlimab (8 mg/kg IV) administered on Day 1 of each 21-day cycle for a total of 4 cycles. Therefore, the study arms mentioned in the model's output are present in the groundtruth study arm table, and the match prediction is 1.",
            "Match prediction: 1\n\nExplanation:\nThe study arms mentioned in the model's output are fully included in the groundtruth study arm table. The model output describes the \"Experimental: Cohort B - Cemiplimab with Fianlimab\" arm, which matches the corresponding arm in the groundtruth table. The details provided in the model output, such as the interventions (cemiplimab and fianlimab), the dosages, and the administration routes, are all consistent with the information given in the groundtruth study arm table.",
            "Match prediction: 1\n\nExplanation:\nThe study arms mentioned in the model's output are fully included in the groundtruth study arm table. The model's output describes two study arms:\n\n1. Experimental: Cohort A - Patients who will receive cemiplimab as the sole treatment.\n2. Experimental: Cohort B - Patients who will receive both cemiplimab and fianlimab in combination.\n\nThese two study arms are present in the groundtruth study arm table, with the same participant groups/arms and intervention/treatment details. The groundtruth table includes the exact information provided in the model's output, including the drug names, dosages, and administration routes.\n\nTherefore, the study arms mentioned in the model's output are fully included in the groundtruth study arm table, and the match prediction is '1'."
        ]
    },
    "NCT06124222": {
        "model_response": [
            "Thank you for providing the necessary information. Based on what you've shared, we can design two study arms. The first study arm will be the experimental arm, which will involve patients who undergo surgical treatment for their head and neck tumor with a need for prosthetic rehabilitation treatment. The intervention for this arm will be the placement of fixed and/or removable prostheses, also known as full dental prostheses. This arm will help assess the effectiveness of full dental prostheses in patients treated for head and neck cancer.",
            "You're welcome! I'm glad I could assist you. Here are the full study arms we've designed:\n\nStudy Arms:\n1. Active Comparator: Group A\n   - Participant Group/Arm: Non-Irradiated Patients\n   - Intervention/Treatment: Prosthetic oral rehabilitation\n\n2. Experimental: Group B\n   - Participant Group/Arm: Irradiated Patients\n   - Intervention/Treatment: Prosthetic oral rehabilitation",
            "Certainly! For study arm 1 (Active Comparator - Group A), participants will need prosthetic oral rehabilitation treatment using either fixed or removable prostheses. For study arm 2 (Experimental - Group B), participants will require prosthetic oral rehabilitation treatment using either fixed or removable prostheses. These interventions/treatments are essential as they directly reflect the objectives of your trial, which is to study the impact of prosthetic rehabilitation on masticatory performance, quality of life, and other outcomes in patients with HNC.",
            "You're welcome! If you have any more questions or need further assistance, feel free to ask. Good luck with your clinical trial!",
            "Exactly! You've designed the study arms perfectly based on the information you provided. Is there anything else I can help you with?"
        ],
        "eval_results": [
            "Match prediction: 1\n\nExplanation:\nThe study arms mentioned in the model's output are fully included in the groundtruth study arm table. The model's output describes two study arms:\n\n1. The experimental arm involving patients who undergo surgical treatment for their head and neck tumor and receive fixed and/or removable prostheses (full dental prostheses) for prosthetic rehabilitation.\n2. The placebo comparator arm involving patients who receive a placebo (non-active study drug).\n\nThese two study arms are present in the groundtruth study arm table, which includes:\n\n1. Active Comparator: Group A - Patients who have not received RT in their oncologic treatment (non-irradiated), receiving prosthetic oral rehabilitation with fixed and/or removable prostheses.\n2. Experimental: Group B - Patients who have received RT in their oncologic treatment (irradiated), receiving prosthetic oral rehabilitation with fixed and/or removable prostheses.\n\nTherefore, the study arms mentioned in the model's output are fully included in the groundtruth study arm table, and the match prediction is '1'.",
            "Match prediction: 1\n\nExplanation:\nThe study arms mentioned in the model's output are fully included in the groundtruth study arm table. The model's output lists two study arms:\n\n1. Active Comparator: Group A\n   - Participant Group/Arm: Non-Irradiated Patients\n   - Intervention/Treatment: Prosthetic oral rehabilitation\n\n2. Experimental: Group B\n   - Participant Group/Arm: Irradiated Patients\n   - Intervention/Treatment: Prosthetic oral rehabilitation\n\nThese two study arms are exactly the same as the ones listed in the groundtruth study arm table. Therefore, the study arms mentioned in the model's output are present in the full table of groundtruth study arms, and the match prediction is '1'.",
            "Match prediction: 1\n\nExplanation:\nThe study arms mentioned in the model's output, \"Active Comparator - Group A\" and \"Experimental - Group B\", are fully included in the groundtruth study arm table. Both the model's output and the groundtruth study arm table describe the same interventions/treatments, which are prosthetic oral rehabilitation using either fixed or removable prostheses. The groundtruth study arm table provides additional details about the participant groups, indicating that Group A includes patients who have not received radiotherapy (RT) in their oncologic treatment, while Group B includes patients who have received RT. However, the core intervention/treatment is the same across both study arms, as described in the model's output.\n\nTherefore, the study arms mentioned in the model's output are present in the full table of groundtruth study arms, and the match prediction is '1'.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms or interventions. It is a general statement about the clinical trial and does not provide any details about the study arms.\n\nThe groundtruth study arm table, on the other hand, lists two study arms: \"Active Comparator: Group A\" and \"Experimental: Group B\". These study arms are not mentioned in the model output, and there is no information about a \"placebo comparator\" or \"HU6\" treatment in the groundtruth table.\n\nTherefore, the study arms mentioned in the model output are not present in the full table of groundtruth study arms, and the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any study arms that are present in the provided groundtruth study arm table. The model output discusses a placebo comparator arm for a study evaluating the drug HU6 in obese subjects with Type 2 Diabetes at risk of Nonalcoholic Steatohepatitis (NASH). However, the groundtruth study arm table does not contain any information about this study or the HU6 drug. Instead, the groundtruth table describes a study comparing prosthetic oral rehabilitation in patients who have and have not received radiation therapy (RT) in their oncologic treatment. Therefore, the study arms mentioned in the model output are not present in the groundtruth study arm table, and the match prediction is 0."
        ]
    },
    "NCT06105775": {
        "model_response": [
            "Thank you for the information. Now, let's discuss the criteria for participant inclusion and exclusion. Could you provide me with those details?",
            "You're welcome! Thank you for using DialogueFlow to design your criteria. I hope this conversation was helpful. If you need any further assistance, please don't hesitate to reach out. Good luck with your clinical trial!",
            "Perfect! Now that we have all the necessary information, let's design the study arms. We have two arms: the Active Comparator: Beetroot juice (BJ) 500mg/day and the Sham Comparator: Placebo (P) group. Based on the information, which arm should we start with?",
            "I'm glad you agree. Now, let's move on to the second study arm. This arm will also involve pregnant women with chronic hypertension. However, the intervention for this arm will be a placebo. This arm is important to establish a baseline and compare the true effects of beetroot juice supplementation with the placebo effects. What are your thoughts on this?",
            "Absolutely. Now that we have designed the experimental arm, let's move on to the control arm. This arm will involve pregnant women with chronic hypertension as well. However, the intervention or treatment for this arm will be a similar juice without nitrate. This arm is necessary to compare the effects of nitrate-enriched beetroot juice. It will provide a placebo to isolate the effects of the intervention. What are your thoughts on this?",
            "I'm glad you agree. Now, let's provide a detailed description of the placebo arm. Participants in this arm will consume a daily 70ml of the placebo juice, which will be made using a non-nitrate juice as a comparator. This arm will also continue with standard pre-eclampsia prophylaxis and their usual antihypertensive treatment. By comparing the outcomes between this placebo group and the experimental group, we can determine the true effects of beetroot juice supplementation.",
            "I'm glad you're satisfied with the design. Here are the full study arms:\nStudy Arms:\n1. Experimental: Beetroot extract juice\n   - Participant Group/Arm: Pregnant women with chronic hypertension\n   - Intervention/Treatment: Dietary Supplement: Nitrate-enriched beetroot extract juice\n   - Description: Starting from the 16th week of gestation, participants will consume a daily 70 ml of nitrate-enriched beetroot extract juice (Beet-It Sport\u00ae from James White Drinks Co in the UK). This juice contains approximately 6.5mmol of nitrate (~400mg). Participants will also continue with standard pre-eclampsia prophylaxis and their usual antihypertensive treatment.\n\n2. Placebo Comparator: Placebo juice\n   - Participant Group/Arm: Pregnant women with chronic hypertension\n   - Intervention/Treatment: Dietary Supplement: Placebo juice\n   - Description: Starting from the 16th week of gestation, participants will consume a daily 70ml of a placebo juice, which is designed to mimic the appearance and taste of the beetroot extract juice. The placebo juice does not contain any active ingredients (beetroot extract. The participants will also continue with standard pre-eclampsia prophylaxis and their usual antihypertensive treatment."
        ],
        "eval_results": [
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms or interventions. It only asks for information about the participant inclusion and exclusion criteria. The groundtruth study arm table, on the other hand, describes two study arms: \"Experimental: Beetroot Juice\" and \"Placebo Comparator: Placebo Juice\". These study arms are not mentioned in the model output, so the study arms from the model output are not fully included in the groundtruth study arm table. Therefore, the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms or interventions. It is a general statement thanking the user for using DialogueFlow and wishing them luck with their clinical trial. \n\nThe groundtruth study arm table, on the other hand, clearly outlines two study arms: an experimental arm receiving nitrate-enriched beetroot extract juice and a placebo comparator arm receiving a placebo juice. \n\nSince the model output does not contain any information about the specific study arms present in the groundtruth table, I cannot evaluate whether the study arms mentioned in the model output are fully included in the groundtruth study arm table. Therefore, the match prediction is 0, indicating that the study arms from the model output are not present in the groundtruth table.",
            "Match prediction: 1\n\nExplanation:\n\nThe study arms mentioned in the model's output, \"Active Comparator: Beetroot juice (BJ) 500mg/day\" and \"Sham Comparator: Placebo (P) group\", are fully included in the groundtruth study arm table. The groundtruth table clearly shows the \"Experimental: Beetroot Juice\" arm, which corresponds to the \"Active Comparator: Beetroot juice (BJ) 500mg/day\" arm in the model's output, and the \"Placebo Comparator: Placebo Juice\" arm, which corresponds to the \"Sham Comparator: Placebo (P) group\" in the model's output.\n\nTherefore, the study arms mentioned in the model's output are present in the full table of groundtruth study arms, and the match prediction is '1'.",
            "Match prediction: 0\n\nExplanation:\n\nThe model output mentions a \"Placebo Comparator: Placebo\" arm, which is not present in the provided groundtruth study arm table. The groundtruth table includes a \"Placebo Comparator: Placebo Juice\" arm, which is different from the one mentioned in the model output. The study arms described in the model output are not fully included in the groundtruth study arm table, so the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\n\nThe model output mentions a \"control arm\" involving \"pregnant women with chronic hypertension\" and a \"similar juice without nitrate\" as the intervention/treatment. However, the groundtruth study arm table does not contain any information about a control arm involving pregnant women with chronic hypertension or a \"similar juice without nitrate\" as the intervention. The groundtruth study arm table only includes an experimental arm with nitrate-enriched beetroot juice and a placebo comparator arm with a placebo juice. \n\nSince the study arms mentioned in the model output are not present in the groundtruth study arm table, the match prediction is 0, indicating that the study arms from the model's output are not included in the groundtruth.",
            "Match prediction: 1\n\nExplanation:\nThe study arms mentioned in the model's output, which are the \"Placebo Comparator: Placebo\" arm and the \"Experimental: Beetroot Juice\" arm, are fully present in the groundtruth study arm table. The descriptions of the interventions and treatments for these arms in the model's output match the corresponding descriptions in the groundtruth table.",
            "Match prediction: 1\n\nExplanation:\nThe study arms mentioned in the model's output are fully included in the groundtruth study arm table. The model's output describes two study arms:\n\n1. Experimental: Beetroot extract juice\n2. Placebo Comparator: Placebo juice\n\nThese two study arms are present in the groundtruth study arm table, with the same participant groups/arms, interventions/treatments, and descriptions.\n\nThe groundtruth study arm table provides the same information as the model's output, including the details about the nitrate-enriched beetroot extract juice and the placebo juice. Therefore, the study arms mentioned in the model's output are fully represented in the groundtruth study arm table."
        ]
    },
    "NCT06230224": {
        "model_response": [
            "Thank you for providing the intervention/treatment options. Now, let's move on to the study type and phase. Could you please provide me with that information?",
            "Understood. Now, let's move on to the criteria for participant selection. Could you please provide me with the inclusion criteria?",
            "Thank you for providing the detailed criteria. Now, let's move on to the design of the study arms. Based on the information you've provided, I suggest considering a single study arm to evaluate the efficacy of odronoxamab compared to standard of care chemotherapy. This arm would include standard of care chemotherapy as part of the first-line treatment. What do you think?",
            "Great! I'm glad you agree. Here are the full study arms for your trial:\n\n1. Experimental: Odronextamab\nParticipant Group/Arm: Participants in this arm will receive odronextamab monotherapy.\nIntervention/Treatment: Drug: Odronextamab\n- Administered by intravenous (IV) infusion\n- Other names: R1979\n\n2. Active Comparator: Standard Of Care\nParticipant Group/Arm: Participants in this arm will receive salvage therapy (ifosfamide, carboplatin, etoposide \u00b1 rituximab [ICE \u00b1 R], or dexamethasone, cisplatin, cytarabine \u00b1 rituximab [DHAP \u00b1 R], or gemcitabine, dexamethasone, cisplatin \u00b1 rituximab [GDP \u00b1 R]) and continue with autologous stem cell transplant (ASCT) following a complete response (CR)/partial response (PR).\nIntervention/Treatment:\n- Drug: Ifosfamide\n- Drug: Carboplatin\n- Drug: Etoposide\n- Drug: Rituximab\n- Drug: Dexamethasone\n- Drug: Cisplatin\n- Drug: Cytarabine\n- Drug: Gemcitabine"
        ],
        "eval_results": [
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms or interventions. It only asks for information about the study type and phase. The groundtruth study arm table, on the other hand, provides details about two study arms: \"Experimental: Odronextamab\" and \"Active Comparator: Standard Of Care\". These study arms are not mentioned in the model output, so the study arms from the model's output are not fully included in the groundtruth study arm table. Therefore, the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output does not mention any specific study arms or interventions. It only asks for the inclusion criteria, which is not provided in the given groundtruth study arm table. The groundtruth table lists the study arms and interventions, but there is no mention of the \"placebo comparator arm\" or \"HU6\" that were described in the model output. Therefore, the study arms mentioned in the model output are not present in the provided groundtruth study arm table, and the match prediction is 0.",
            "Match prediction: 0\n\nExplanation:\nThe model output mentions a single study arm to evaluate the efficacy of odronoxamab compared to standard of care chemotherapy. However, the groundtruth study arm table does not contain a study arm with this specific design. The groundtruth table includes two study arms:\n\n1. Experimental: Odronextamab - This arm evaluates the efficacy of odronextamab monotherapy.\n2. Active Comparator: Standard Of Care - This arm evaluates the efficacy of standard of care chemotherapy (ifosfamide, carboplatin, etoposide \u00b1 rituximab [ICE \u00b1 R], or dexamethasone, cisplatin, cytarabine \u00b1 rituximab [DHAP \u00b1 R], or gemcitabine, dexamethasone, cisplatin \u00b1 rituximab [GDP \u00b1 R]) and autologous stem cell transplant (ASCT).\n\nThe study arm mentioned in the model output, which compares odronoxamab to standard of care chemotherapy, is not present in the groundtruth study arm table. Therefore, the match prediction is 0, indicating that the study arms from the model's output are not included in the groundtruth study arm table.",
            "Match prediction: 1\n\nExplanation:\nThe study arms mentioned in the model's output are fully included in the groundtruth study arm table. The model's output lists two study arms:\n\n1. Experimental: Odronextamab\n2. Active Comparator: Standard Of Care\n\nBoth of these study arms are present in the groundtruth study arm table, with the same participant group/arm names and intervention/treatment details.\n\nThe groundtruth study arm table provides a comprehensive list of all the study arms, including the two mentioned in the model's output. Therefore, the study arms from the model's output are fully included in the groundtruth study arm table, and the match prediction is '1'."
        ]
    }
}